Future of antivirals in COVID-19: The case of favipiravir.

Authors	Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Journal	International immunopharmacology (Int Immunopharmacol) Vol. 103 Pg. 108455 (Feb 2022) ISSN: 1878-1705 [Electronic] Netherlands
PMID	34959188 (Publication Type: Letter, Meta-Analysis)
Chemical References	Amides Antiviral Agents Pyrazines favipiravir
Topics	Amides (therapeutic use) Antiviral Agents (therapeutic use) COVID-19 (mortality) Humans Pyrazines (therapeutic use) Randomized Controlled Trials as Topic Treatment Outcome COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!